These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 1704847

  • 1. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U.
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [Abstract] [Full Text] [Related]

  • 2. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 3. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Ohlin M, Valentino KL, Ungerstedt U.
    Neuroscience; 1990 Jun 11; 36(3):643-58. PubMed ID: 1700329
    [Abstract] [Full Text] [Related]

  • 4. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS, Hökfelt T, Herrera-Marschitz M, Håkanson R, Feng DM, Folkers K, Goldstein M, Ungerstedt U.
    Brain Res; 1990 Nov 05; 532(1-2):175-81. PubMed ID: 1704289
    [Abstract] [Full Text] [Related]

  • 5. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M, Herrera-Marschitz M, Hökfelt T, Terenius L, Ungerstedt U.
    Eur J Pharmacol; 1988 Mar 15; 147(3):411-20. PubMed ID: 2454197
    [Abstract] [Full Text] [Related]

  • 6. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hökfelt T, Terenius L, Ungerstedt U.
    Exp Brain Res; 1986 Mar 15; 64(1):193-207. PubMed ID: 2429859
    [Abstract] [Full Text] [Related]

  • 7. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I, Herrera-Marschitz M, Staines W, Hökfelt T, Terenius L, Ungerstedt U, Cuello C, Oertel WH, Goldstein M.
    Exp Brain Res; 1986 Mar 15; 64(1):169-92. PubMed ID: 2429858
    [Abstract] [Full Text] [Related]

  • 8. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
    Reid MS, Herrera-Marschitz M, Ungerstedt U.
    Neuroscience; 1990 Mar 15; 36(3):659-67. PubMed ID: 1700330
    [Abstract] [Full Text] [Related]

  • 9. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
    Reid MS, Herrera-Marschitz M, Ungerstedt U.
    J Neurochem; 1991 Sep 15; 57(3):970-4. PubMed ID: 1713616
    [Abstract] [Full Text] [Related]

  • 10. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U.
    Acta Physiol Scand; 1990 Dec 15; 140(4):527-37. PubMed ID: 1707211
    [Abstract] [Full Text] [Related]

  • 11. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS, Herrera-Marschitz M, Terenius L, Ungerstedt U.
    Brain Res; 1990 Sep 03; 526(2):228-34. PubMed ID: 1701682
    [Abstract] [Full Text] [Related]

  • 12. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
    Baruch P, Artaud F, Godeheu G, Barbeito L, Glowinski J, Chéramy A.
    Neuroscience; 1988 Jun 03; 25(3):889-98. PubMed ID: 2457187
    [Abstract] [Full Text] [Related]

  • 13. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
    You ZB, Nylander I, Herrera-Marschitz M, O'Connor WT, Goiny M, Terenius L.
    Neuroscience; 1994 Nov 03; 63(2):415-25. PubMed ID: 7891855
    [Abstract] [Full Text] [Related]

  • 14. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N, Brodin E, Tossman U, Segovia J, Ungerstedt U.
    Exp Brain Res; 1989 Nov 03; 74(3):527-34. PubMed ID: 2468514
    [Abstract] [Full Text] [Related]

  • 15. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
    Tan DP, Tsou K.
    Brain Res; 1988 Mar 08; 443(1-2):310-4. PubMed ID: 2451993
    [Abstract] [Full Text] [Related]

  • 16. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F.
    Neuroscience; 1993 Apr 08; 53(3):639-50. PubMed ID: 8098137
    [Abstract] [Full Text] [Related]

  • 17. Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents.
    Campbell K, Kalén P, Wictorin K, Lundberg C, Mandel RJ, Björklund A.
    Neuroscience; 1993 Mar 08; 53(2):403-15. PubMed ID: 8098510
    [Abstract] [Full Text] [Related]

  • 18. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou HZ, Kehr J, Godukhin O, Hökfelt T, Terenius L, Ungerstedt U.
    Neuroscience; 1996 Oct 08; 74(3):793-804. PubMed ID: 8884775
    [Abstract] [Full Text] [Related]

  • 19. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB, Herrera-Marschitz M, Nylander I, Goiny M, O'Connor WT, Ungerstedt U, Terenius L.
    Neuroscience; 1994 Nov 08; 63(2):427-34. PubMed ID: 7891856
    [Abstract] [Full Text] [Related]

  • 20. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR, McGinty JF, Young WS.
    J Neurosci; 1991 Apr 08; 11(4):1016-31. PubMed ID: 1707092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.